{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:00:08Z","timestamp":1794330008167,"version":"4.9.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic has introduced major disruptions in clinical practices, including infection management strategies and antibiotic prescribing habits. This study aimed to investigate changes in the distribution of respiratory pathogens and their antimicrobial resistance (AMR) patterns in intensive care units (ICUs) before and after the onset of COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cross-sectional study, 1,662 respiratory tract samples (bronchoalveolar lavage, deep tracheal aspirate, and sputum) collected from ICU patients at a tertiary hospital in Turkey between January 1, 2016 and December 31, 2024 were analyzed. The study compared bacterial isolates and resistance profiles between the pre-pandemic (January 2016\u2013Feb 2020) and post-pandemic (Mar 2020\u2013December 2024) periods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      and\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      remained the most frequently isolated pathogens throughout the study. Post-pandemic, resistance rates increased significantly for several antibiotics, particularly against\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      (gentamicin: 70.9% to 91.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; colistin: 3.2% to 12.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (carbapenems:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; colistin: 23% to 62.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). For\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      , meropenem, piperacillin-tazobactam, and ceftazidime resistance rates increased significantly after the post-pandemic period (33.9% to 52.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003; 50.4% to 65.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011; 27.9% to 56.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). The changes in resistance rates of\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      were not statistically significant and also showed a reduced isolation rate post-pandemic (11.4% to 7.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Among Gram-positive isolates, only\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      showed a significant increase in vancomycin resistance (50.0% vs. 0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046). In contrast, no significant findings were observed for methicillin resistance in\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA) and vancomycin resistance in\n                      <jats:italic>Enterococcus faecalis<\/jats:italic>\n                      (31.3% vs. 28.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.823; and 25% vs. 0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.285, respectively). Mortality also increased significantly during the post-pandemic period (70.5% to 74.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048), alongside a higher prevalence of comorbidities such as hypertension and coronary artery disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings highlight a marked escalation in AMR following the COVID-19 pandemic, likely driven by increased empirical antibiotic use, prolonged ICU stays, expanded use of invasive procedures, and broader steroid administration. This study underscores the deepening AMR crisis in ICUs and provides critical data from Turkey that may support global antimicrobial stewardship efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12140-6","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:51:35Z","timestamp":1764766295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Investigation of antibiotic resistance against pathogens isolated from respiratory samples in intensive care units after SARS-CoV-2 pandemic"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-342X","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00c7apar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2776-740X","authenticated-orcid":false,"given":"Derya","family":"\u00d6zyi\u011fito\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-6508","authenticated-orcid":false,"given":"\u015eeyma","family":"Ba\u015fl\u0131lar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"6","key":"12140_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/antibiotics13060512","volume":"13","author":"E Hogea","year":"2024","unstructured":"Hogea E, Muntean AC, Bratosin F, Bogdan IG, Plavitu O, Fratutu A, et al. Antibiotic resistance trends in uropathogens during the COVID-19 pandemic in Western romania: a cross-sectional study. Antibiotics. 2024;13(6):512.","journal-title":"Antibiotics"},{"issue":"6","key":"12140_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/pathogens12060780","volume":"12","author":"V Petrakis","year":"2023","unstructured":"Petrakis V, Panopoulou M, Rafailidis P, Lemonakis N, Lazaridis G, Terzi I, et al. The impact of the COVID-19 pandemic on antimicrobial resistance and management of bloodstream infections. Pathogens. 2023;12(6):780.","journal-title":"Pathogens"},{"key":"12140_CR3","doi-asserted-by":"publisher","first-page":"e64139","DOI":"10.7554\/eLife.64139","volume":"10","author":"GM Knight","year":"2021","unstructured":"Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, et al. Antimicrobial resistance and COVID-19: intersections and implications. Elife. 2021;10:e64139.","journal-title":"Elife"},{"issue":"10459","key":"12140_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"issue":"4","key":"12140_CR5","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.ijantimicag.2021.106324","volume":"57","author":"C-C Lai","year":"2021","unstructured":"Lai C-C, Chen S-Y, Ko W-C, Hsueh P-R. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57(4):106324.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"12140_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmi.2022.12.006","volume":"29","author":"BJ Langford","year":"2023","unstructured":"Langford BJ, Soucy J-PR, Leung V, So M, Kwan AT, Portnoff JS, et al. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(3):302\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"12140_CR7","doi-asserted-by":"publisher","first-page":"106183","DOI":"10.1016\/j.jinf.2024.106183","volume":"89","author":"X Yang","year":"2024","unstructured":"Yang X, Li X, Qiu S, Liu C, Chen S, Xia H, et al. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data. J Infect. 2024;89(1):106183.","journal-title":"J Infect"},{"issue":"2","key":"12140_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/microbiolres14020052","volume":"14","author":"O Khaznadar","year":"2023","unstructured":"Khaznadar O, Khaznadar F, Petrovic A, Kuna L, Loncar A, Omanovic Kolaric T, et al. Antimicrobial resistance and antimicrobial stewardship: Before, during and after the COVID-19 pandemic. Microbiol Res. 2023;14(2):727\u201340.","journal-title":"Microbiol Res"},{"issue":"4","key":"12140_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jiph.2023.02.021","volume":"16","author":"S Rehman","year":"2023","unstructured":"Rehman S. A parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic. J Infect Public Health. 2023;16(4):611\u20137.","journal-title":"J Infect Public Health"},{"issue":"1","key":"12140_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41479-024-00137-9","volume":"16","author":"J Rukyaa","year":"2024","unstructured":"Rukyaa J, Mushi MF, Silago V, Damiano P, Keenan K, Sabiiti W, et al. Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, tanzania: a cross-sectional study. Pneumonia. 2024;16(1):16.","journal-title":"Pneumonia"},{"issue":"1","key":"12140_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jmv.27351","volume":"94","author":"H Yaqoob","year":"2022","unstructured":"Yaqoob H, Greenberg D, Hwang F, Lee C, Vernik D, Manglani R, et al. Comparison of pulse-dose and high\u2010dose corticosteroids with no corticosteroid treatment for COVID\u201019 pneumonia in the intensive care unit. J Med Virol. 2022;94(1):349\u201356.","journal-title":"J Med Virol"},{"issue":"1","key":"12140_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4266\/acc.2022.00941","volume":"38","author":"K-J Choi","year":"2023","unstructured":"Choi K-J, Jung SK, Kim KC, Kim EJ. Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study. Acute Crit Care. 2023;38(1):57.","journal-title":"Acute Crit Care"},{"issue":"3","key":"12140_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/antibiotics13030233","volume":"13","author":"L Boccabella","year":"2024","unstructured":"Boccabella L, Palma EG, Abenavoli L, Scarlata GGM, Boni M, Ianiro G, et al. Post-Coronavirus disease 2019 pandemic antimicrobial resistance. Antibiotics. 2024;13(3):233.","journal-title":"Antibiotics"},{"issue":"2","key":"12140_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s13337-021-00695-2","volume":"32","author":"SH Subramanya","year":"2021","unstructured":"Subramanya SH, Czy\u017c DM, Acharya KP, Humphreys H. The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship. Virusdisease. 2021;32(2):330\u20137.","journal-title":"Virusdisease"},{"key":"12140_CR15","doi-asserted-by":"publisher","first-page":"1565965","DOI":"10.3389\/fmicb.2025.1565965","volume":"16","author":"A Yehya","year":"2025","unstructured":"Yehya A, Ezzeddine Z, Chakkour M, Dhaini Z, Saba MSB, Saba ASB, et al. The intricacies of Acinetobacter baumannii: a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications. Front Microbiol. 2025;16:1565965.","journal-title":"Front Microbiol"},{"issue":"2","key":"12140_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biology13020078","volume":"13","author":"R Abbas","year":"2024","unstructured":"Abbas R, Chakkour M, Zein El Dine H, Obaseki EF, Obeid ST, Jezzini A, et al. General overview of Klebsiella pneumonia: epidemiology and the role of siderophores in its pathogenicity. Biology. 2024;13(2):78.","journal-title":"Biology"},{"issue":"19","key":"12140_CR17","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.3390\/ijerph191911931","volume":"19","author":"HJA Sulayyim","year":"2022","unstructured":"Sulayyim HJA, Ismail R, Hamid AA, Ghafar NA. Antibiotic resistance during COVID-19: a systematic review. Int J Environ Res Public Health. 2022;19(19):11931.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"12140_CR18","doi-asserted-by":"publisher","first-page":"102453","DOI":"10.1016\/j.jiph.2024.05.041","volume":"17","author":"L Orosz","year":"2024","unstructured":"Orosz L, Buri\u00e1n K. The COVID effect in culture-based clinical microbiology: changes induced by COVID-19 pandemic in a Hungarian tertiary care center. J Infect Public Health. 2024;17(7):102453.","journal-title":"J Infect Public Health"},{"key":"12140_CR19","doi-asserted-by":"crossref","unstructured":"Elfadadny A, Ragab R, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A et al. Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol. 2024;15:1374466.","DOI":"10.3389\/fmicb.2024.1374466"},{"issue":"9","key":"12140_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/antibiotics13090797","volume":"13","author":"K Hrovat","year":"2024","unstructured":"Hrovat K, Seme K, Ambro\u017ei\u010d Avgu\u0161tin J. Increasing fluroquinolone susceptibility and genetic diversity of ESBL-Producing E. coli from the lower respiratory tract during the COVID-19 pandemic. Antibiotics. 2024;13(9):797.","journal-title":"Antibiotics"},{"issue":"1","key":"12140_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12866-023-02773-5","volume":"23","author":"AM Abdel Gawad","year":"2023","unstructured":"Abdel Gawad AM, Ashry WMO, El-Ghannam S, Hussein M, Yousef A. Antibiotic resistance profile of common uropathogens during COVID-19 pandemic: hospital based epidemiologic study. BMC Microbiol. 2023;23(1):28.","journal-title":"BMC Microbiol"},{"issue":"1","key":"12140_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12866-025-04335-3","volume":"25","author":"NA El Aila","year":"2025","unstructured":"El Aila NA, El Aish KIA. Six-year antimicrobial resistance patterns of Escherichia coli isolates from different hospitals in Gaza, Palestine. BMC Microbiol. 2025;25(1):559.","journal-title":"BMC Microbiol"},{"key":"12140_CR23","doi-asserted-by":"crossref","unstructured":"Gherardi G. Staphylococcus aureus infection: pathogenesis and antimicrobial resistance. MDPI; 2023:8182.","DOI":"10.3390\/ijms24098182"},{"key":"12140_CR24","doi-asserted-by":"publisher","first-page":"1336821","DOI":"10.3389\/fcimb.2024.1336821","volume":"14","author":"K Liu","year":"2024","unstructured":"Liu K, Wang C, Zhou X, Guo X, Yang Y, Liu W, et al. Bacteriophage therapy for drug-resistant Staphylococcus aureus infections. Front Cell Infect Microbiol. 2024;14:1336821.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"12140_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/diagnostics14111190","volume":"14","author":"A Al Bshabshe","year":"2024","unstructured":"Al Bshabshe A, Algarni A, Shabi Y, Alwahhabi A, Asiri M, Alasmari A, et al. Characterization and antimicrobial susceptibility patterns of Enterococcus species isolated from nosocomial infections in a Saudi tertiary care hospital over a Ten-Year period (2012\u20132021). Diagnostics. 2024;14(11):1190.","journal-title":"Diagnostics"},{"issue":"6","key":"12140_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmi.2019.02.024","volume":"25","author":"B Isler","year":"2019","unstructured":"Isler B, Keske \u015e, Aksoy M, Azap \u00d6K, Yilmaz M, Yavuz S, et al. Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect. 2019;25(6):651\u20133.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12140-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:51:38Z","timestamp":1764766298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-12140-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12140"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12140-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ministry of Health, Istanbul Health Sciences University, Umraniye Training and Research Hospital Scientific Research Ethics Committee (11 July 2024; B.10.1.TKH.4.34.H.GP.0.01\/203). And the study was conducted by the principles of the Declaration of Helsinki. Following the official policy of the Observational Ethics Committees of the University of Health Sciences, Republic of Turkey, informed consent was not required from participants, as this study was a retrospective observational investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Since the study was a retrospective study, informed consent was not obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1691"}}